Cargando…
Impairment of IFN-Gamma Response to Synthetic Peptides of Mycobacterium tuberculosis in a 7-Day Whole Blood Assay
Studies on Mycobacterium tuberculosis (MTB) antigens are of interest in order to improve vaccine efficacy and to define biomarkers for diagnosis and treatment monitoring. The methodologies used for these investigations differ greatly between laboratories and discordant results are common. The IFN-ga...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3738639/ https://www.ncbi.nlm.nih.gov/pubmed/23951140 http://dx.doi.org/10.1371/journal.pone.0071351 |
_version_ | 1782476872727134208 |
---|---|
author | Gideon, Hannah Priyadarshini Hamilton, Melissa Shea Wood, Kathryn Pepper, Dominique Oni, Tolu Seldon, Ronnett Banwell, Claire Langford, Paul R. Wilkinson, Robert J. Wilkinson, Katalin A. |
author_facet | Gideon, Hannah Priyadarshini Hamilton, Melissa Shea Wood, Kathryn Pepper, Dominique Oni, Tolu Seldon, Ronnett Banwell, Claire Langford, Paul R. Wilkinson, Robert J. Wilkinson, Katalin A. |
author_sort | Gideon, Hannah Priyadarshini |
collection | PubMed |
description | Studies on Mycobacterium tuberculosis (MTB) antigens are of interest in order to improve vaccine efficacy and to define biomarkers for diagnosis and treatment monitoring. The methodologies used for these investigations differ greatly between laboratories and discordant results are common. The IFN-gamma response to two well characterized MTB antigens ESAT-6 and CFP-10, in the form of recombinant proteins and synthetic peptides, was evaluated in HIV-1 uninfected persons in both long-term (7 day) and 24 hour, commercially available QuantiFERON TB Gold in Tube (QFT-GIT), whole blood assays. Our findings showed differences in the IFN-gamma response between 24 hour and 7 day cultures, with recombinant proteins inducing a significantly higher response than the peptide pools in 7 day whole blood assays. The activity of peptides and recombinant proteins did not differ in 24 hour whole blood or peripheral blood mononuclear cell (PBMC) based assays, nor in the ELISpot assay. Further analysis by SELDI-TOF mass spectrometry showed that the peptides are degraded over the course of 7 days of incubation in whole blood whilst the recombinant proteins remain intact. This study therefore demonstrates that screening antigenic candidates as synthetic peptides in long-term whole blood assays may underestimate immunogenicity. |
format | Online Article Text |
id | pubmed-3738639 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2013 |
publisher | Public Library of Science |
record_format | MEDLINE/PubMed |
spelling | pubmed-37386392013-08-15 Impairment of IFN-Gamma Response to Synthetic Peptides of Mycobacterium tuberculosis in a 7-Day Whole Blood Assay Gideon, Hannah Priyadarshini Hamilton, Melissa Shea Wood, Kathryn Pepper, Dominique Oni, Tolu Seldon, Ronnett Banwell, Claire Langford, Paul R. Wilkinson, Robert J. Wilkinson, Katalin A. PLoS One Research Article Studies on Mycobacterium tuberculosis (MTB) antigens are of interest in order to improve vaccine efficacy and to define biomarkers for diagnosis and treatment monitoring. The methodologies used for these investigations differ greatly between laboratories and discordant results are common. The IFN-gamma response to two well characterized MTB antigens ESAT-6 and CFP-10, in the form of recombinant proteins and synthetic peptides, was evaluated in HIV-1 uninfected persons in both long-term (7 day) and 24 hour, commercially available QuantiFERON TB Gold in Tube (QFT-GIT), whole blood assays. Our findings showed differences in the IFN-gamma response between 24 hour and 7 day cultures, with recombinant proteins inducing a significantly higher response than the peptide pools in 7 day whole blood assays. The activity of peptides and recombinant proteins did not differ in 24 hour whole blood or peripheral blood mononuclear cell (PBMC) based assays, nor in the ELISpot assay. Further analysis by SELDI-TOF mass spectrometry showed that the peptides are degraded over the course of 7 days of incubation in whole blood whilst the recombinant proteins remain intact. This study therefore demonstrates that screening antigenic candidates as synthetic peptides in long-term whole blood assays may underestimate immunogenicity. Public Library of Science 2013-08-08 /pmc/articles/PMC3738639/ /pubmed/23951140 http://dx.doi.org/10.1371/journal.pone.0071351 Text en © 2013 Gideon et al http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are properly credited. |
spellingShingle | Research Article Gideon, Hannah Priyadarshini Hamilton, Melissa Shea Wood, Kathryn Pepper, Dominique Oni, Tolu Seldon, Ronnett Banwell, Claire Langford, Paul R. Wilkinson, Robert J. Wilkinson, Katalin A. Impairment of IFN-Gamma Response to Synthetic Peptides of Mycobacterium tuberculosis in a 7-Day Whole Blood Assay |
title | Impairment of IFN-Gamma Response to Synthetic Peptides of Mycobacterium tuberculosis in a 7-Day Whole Blood Assay |
title_full | Impairment of IFN-Gamma Response to Synthetic Peptides of Mycobacterium tuberculosis in a 7-Day Whole Blood Assay |
title_fullStr | Impairment of IFN-Gamma Response to Synthetic Peptides of Mycobacterium tuberculosis in a 7-Day Whole Blood Assay |
title_full_unstemmed | Impairment of IFN-Gamma Response to Synthetic Peptides of Mycobacterium tuberculosis in a 7-Day Whole Blood Assay |
title_short | Impairment of IFN-Gamma Response to Synthetic Peptides of Mycobacterium tuberculosis in a 7-Day Whole Blood Assay |
title_sort | impairment of ifn-gamma response to synthetic peptides of mycobacterium tuberculosis in a 7-day whole blood assay |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3738639/ https://www.ncbi.nlm.nih.gov/pubmed/23951140 http://dx.doi.org/10.1371/journal.pone.0071351 |
work_keys_str_mv | AT gideonhannahpriyadarshini impairmentofifngammaresponsetosyntheticpeptidesofmycobacteriumtuberculosisina7daywholebloodassay AT hamiltonmelissashea impairmentofifngammaresponsetosyntheticpeptidesofmycobacteriumtuberculosisina7daywholebloodassay AT woodkathryn impairmentofifngammaresponsetosyntheticpeptidesofmycobacteriumtuberculosisina7daywholebloodassay AT pepperdominique impairmentofifngammaresponsetosyntheticpeptidesofmycobacteriumtuberculosisina7daywholebloodassay AT onitolu impairmentofifngammaresponsetosyntheticpeptidesofmycobacteriumtuberculosisina7daywholebloodassay AT seldonronnett impairmentofifngammaresponsetosyntheticpeptidesofmycobacteriumtuberculosisina7daywholebloodassay AT banwellclaire impairmentofifngammaresponsetosyntheticpeptidesofmycobacteriumtuberculosisina7daywholebloodassay AT langfordpaulr impairmentofifngammaresponsetosyntheticpeptidesofmycobacteriumtuberculosisina7daywholebloodassay AT wilkinsonrobertj impairmentofifngammaresponsetosyntheticpeptidesofmycobacteriumtuberculosisina7daywholebloodassay AT wilkinsonkatalina impairmentofifngammaresponsetosyntheticpeptidesofmycobacteriumtuberculosisina7daywholebloodassay |